CREKA-lipo-anti-IFNγ combined with cisplatin reduces tumour weight compared with that in control group mice, whereas lactate abrogates the effect of CREKA-lipo-anti-IFNγ (Figure 6E). This evidence concerns the gene IFNG and neoplasm.